Additionally, a study among 158 ovarian cancer patients (37 BRCA-mutated, 121 BRCA-wildtype) showed that BRCA-mutated tumors had significantly higher levels of PD-1 and PD-L1 mRNA as compared to BRCA wild-type tumors [57]. The gene discussed is PDCD1; the disease is ovarian carcinoma.